169 related articles for article (PubMed ID: 20616582)
1. Molecular signature of early hepatocellular carcinoma.
Suriawinata A; Thung SN
Oncology; 2010 Jul; 78 Suppl 1():36-9. PubMed ID: 20616582
[TBL] [Abstract][Full Text] [Related]
2. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
[TBL] [Abstract][Full Text] [Related]
3. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.
Sakamoto M; Mori T; Masugi Y; Effendi K; Rie I; Du W
Intervirology; 2008; 51 Suppl 1():42-5. PubMed ID: 18544947
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis of multistage hepatocarcinogenesis.
Sakamoto M; Effendi K; Masugi Y
Jpn J Clin Oncol; 2010 Sep; 40(9):891-6. PubMed ID: 20603246
[TBL] [Abstract][Full Text] [Related]
5. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
Peng XQ; Wang F; Geng X; Zhang WM
Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in tumor markers of human hepatocellular carcinoma.
Yoon SK
Intervirology; 2008; 51 Suppl 1():34-41. PubMed ID: 18544946
[TBL] [Abstract][Full Text] [Related]
7. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
8. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Frau M; Biasi F; Feo F; Pascale RM
Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
Sherman M
Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
[TBL] [Abstract][Full Text] [Related]
10. High-dimensional biology to comprehend hepatocellular carcinoma.
Vivekanandan P; Singh OV
Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
[TBL] [Abstract][Full Text] [Related]
11. Shaping the future management of hepatocellular carcinoma.
Abou-Alfa G; Colombo M
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
Kudo M
Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
[TBL] [Abstract][Full Text] [Related]
13. Liver precancerous lesions and hepatocellular carcinoma: the histology report.
Roncalli M; Terracciano L; Di Tommaso L; David E; Colombo M; ;
Dig Liver Dis; 2011 Mar; 43 Suppl 4():S361-72. PubMed ID: 21459342
[TBL] [Abstract][Full Text] [Related]
14. High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Unoura M; Kaneko S; Matsushita E; Shimoda A; Takeuchi M; Adachi H; Kawai H; Urabe T; Yanagi M; Matsui O
Hepatogastroenterology; 1993 Aug; 40(4):305-10. PubMed ID: 8406298
[TBL] [Abstract][Full Text] [Related]
15. Pathological diagnosis at early stage: reaching international consensus.
Kojiro M
Oncology; 2010 Jul; 78 Suppl 1():31-5. PubMed ID: 20616581
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: diagnostics and screening.
Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD
J Eval Clin Pract; 2012 Apr; 18(2):335-42. PubMed ID: 21114800
[TBL] [Abstract][Full Text] [Related]
17. The loss of phenol sulfotransferase 1 in hepatocellular carcinogenesis.
Yeo M; Na YM; Kim DK; Kim YB; Wang HJ; Lee JA; Cheong JY; Lee KJ; Paik YK; Cho SW
Proteomics; 2010 Jan; 10(2):266-76. PubMed ID: 19904771
[TBL] [Abstract][Full Text] [Related]
18. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
[TBL] [Abstract][Full Text] [Related]
19. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.
Roskams T; Kojiro M
Semin Liver Dis; 2010 Feb; 30(1):17-25. PubMed ID: 20175030
[TBL] [Abstract][Full Text] [Related]
20. Advances in prevention and diagnosis of hepatocellular carcinoma.
Spangenberg HC; Thimme R; Blum HE
Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):425-33. PubMed ID: 19072390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
